![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Supuran Claudiu T
Publisher: Informa Healthcare
ISSN: 1354-3776
Source: Expert Opinion on Therapeutic Patents, Vol.21, Iss.9, 2011-09, pp. : 1491-1495
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Antagonists of IL-1R: a patent evaluation (WO2012122985)
Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 7, 2013-07 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Lipka Daniel B Kuck Dirk Kliem Christian Gerhauser Clarissa
Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 4, 2013-04 ,pp. :